Preview

Russian Journal of Cardiology

Advanced search

Prevalence of hypertension, levels of lipids and blood glucose in patients with acute pancreatitis, chronic pancreatitis and pancreatic cancer

https://doi.org/10.15829/1560-4071-2020-3823

Abstract

Aim. To determine the prevalence of hypertension (HTN) in patients with acute pancreatitis (AP), chronic pancreatitis (CP), pancreatic cancer (PC) and establish associations of HTN with other risk factors (obesity, dyslipidemia (DLP), plasma glucose ≥7,0 mmol/l, smoking, alcohol consumption).

Material and methods. This observational multicenter clinical cross-sectional uncontrolled study included 44 patients with AP, 97 patients with CP and 45 patients with PC. The groups were comparable by sex and age. The HTN was diagnosed according to the criteria of Russian Society of Cardiology (2020).

Results. HTN was much more common in patients with PC (55,6%) than in patients with AP (25,0%) (χ 2 =8,6, p=0,003). In patients with CP, the prevalence of HTN (39,2%) did not differ from those with AP or PC. Among patients with AP and HTN, higher levels of triglycerides (TG) (U=88,0, p=0,010) and glucose (U=89,5, p=0,011) than in non-HTN patients with AP were determined. In HTN patients with CP, glucose ≥7,0 mmol/l was recorded 3 times more often than in non-HTN patients with CP (χ 2 =16,2, p=0,000). In patients with PC and HTN, a higher mean body mass index (BMI) (F=7,8, p=0,008) and less common normal body weight than in non-HTN patients with PC (28,0 and 65,0%, χ 2 =6,2, p=0,013) was revealed. In patients with CP, increased glucose levels by 1 mmol/l (Exp (B)=1,933, 95% confidence interval (CI) 1,350-2,767, p=0,000) or BMI by 1 kg/m2 (Exp (B)=1,224, 95% CI 1,085-1,380, p=0,001) raised the probability of HTN; in patients with PC, increased BMI by 1 kg/ m2 (Exp (B)=1,394, 95% CI 1,057-1,840, p=0,019) or age by 1 year (Exp (B)=1,251, 95% CI 1,052-1,489, p=0,011) raised the probability of HTN.

Conclusion. HTN was more often observed in patients with PC than in those with AP. In patients with CP, the prevalence of HTN did not differ from those with AP or PC. HTN was a cofactor to other metabolic risk factors (glucose ≥7,0 mmol/l, obesity) in patients with AP or CP; behavioral risk factors, on the contrary, were less common in HTN patients with AP or CP. In patients with CP, there was a direct association of HTN with glucose levels or BMI, and in patients with PC — HTN with BMI or age.

About the Authors

I. N. Grigorieva
Research Institute of Therapy and Preventive Medicine — a branch of the Federal Research Center Institute of Cytology and Genetics
Russian Federation
Novosibirsk


O. V. Efimova
Research Institute of Therapy and Preventive Medicine — a branch of the Federal Research Center Institute of Cytology and Genetics
Russian Federation
Novosibirsk


T. S. Suvorova
Research Institute of Therapy and Preventive Medicine — a branch of the Federal Research Center Institute of Cytology and Genetics
Russian Federation
Novosibirsk


N. L. Tov
Research Institute of Therapy and Preventive Medicine — a branch of the Federal Research Center Institute of Cytology and Genetics
Novosibirsk


T. I. Romanova
Research Institute of Therapy and Preventive Medicine — a branch of the Federal Research Center Institute of Cytology and Genetics
Novosibirsk


References

1. Xiao AY, Tan ML, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016;1(1):45-55. doi:10.1016/S2468-1253(16)30004-8.

2. Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016 Aug 9;134(6):441-50. doi:10.1161/CIRCULATIONAHA.115.018912.

3. Grigorieva IN, Ragino YuI, Romanova TI. Epidemiology and comorbidity of arterial hypertension and gallstone disease. Russian Journal of Cardiology. 2019;24(6):143-8. (In Russ.) doi:10.15829/1560-4071-2019-6-143-148.

4. Nowińska P, Kasacka I. Changes in the pancreas caused by different types of hypertension. Acta Biochim Pol. 2017;64(4):591-5. doi:10.18388/abp.2017_1504.

5. Liu R, Qi H, Wang J, et al. Angiotensin-converting enzyme (ACE and ACE2) imbalance correlates with the severity of cerulein-induced acute pancreatitis in mice. Exp. Physiol. 2014;99:651-63. doi:10.1113/expphysiol.2013.074815.

6. Nehme A, Zouein FZ, Zayeri ZD, et al. An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology. J Cardiovasc Dev Dis. 2019;6(2):14. doi:10.3390/jcdd6020014.

7. Degtyareva LN, Kuznetsova OYu, Plavinsky SL, et al. Using the method of modifying the patient’s behavior in case of dangerous and harmful use of alcohol. Russian family doctor. 2012;16(1):55-64. (In Russ).

8. Kobalava ZD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.) Clinical recommendations. Arterial hypertension in adults. 2020. (In Russ.) doi:10.15829/1560-4071-2020-3-3786.

9. Nordestgaard BG, Langsted A, Mora S, et al. Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement From the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2016;62(7):930-46. doi:10.1373/clinchem.2016.258897.

10. Grigorieva IN. Acute and chronic pancreatitis. Novosibirsk Publishing house Science; 2011. 101 p. (In Russ.)

11. Muromtseva GA, Kontsevaya AV, Konstantinov VV, et al. Prevalence of risk factors for noncommunicable diseases in the Russian population in 2012-2013. The results of the study ESSE-RF. Cardiovascular therapy and prevention. 2014;13(6):4-11. (In Russ.) doi:10.15829/1728-8800-2014-6-4-11.

12. Chung JW, Ryu SH, Jo JH, et al. Clinical implications and risk factors of acute pancreatitis after cardiac valve surgery. Yonsei Med J. 2013;54(1):154-9. doi:10.3349/ymj.2013.54.1.154.

13. Bexelius TS, Ljung R, Mattsson F, et al. Angiotensin II receptor blockers and risk of acute pancreatitis — a population based case-control study in Sweden. BMC Gastroenterol. 2017;17(1):36. doi:10.1186/s12876-017-0595-8.

14. Choi J, Jang J, An Y, et al. Blood Pressure and the Risk of Death From Non-cardiovascular Diseases: A Population-based Cohort Study of Korean Adults. J Prev Med Public Health. 2018;51(6):298-309. doi:10.3961/jpmph.18.212.

15. Nikolic S, Dugic A, Steiner C, et al. Chronic pancreatitis and the heart disease: Still terra incognita? World J Gastroenterol. 2019;25(44):6561-70. doi:10.3748/wjg.v25.i44.6561.

16. de la Iglesia D, Vallejo-Senra N, López-López A, et al. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study. J Gastroenterol Hepatol. 2019;34(1):277-83. doi:10.1111/jgh.14460.

17. Mouhayar E, Salahudeen A. Hypertension in Cancer Patients. Tex Heart Inst J. 2011;38(3):263-65.


Review

For citations:


Grigorieva I.N., Efimova O.V., Suvorova T.S., Tov N.L., Romanova T.I. Prevalence of hypertension, levels of lipids and blood glucose in patients with acute pancreatitis, chronic pancreatitis and pancreatic cancer. Russian Journal of Cardiology. 2020;25(6):3823. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3823

Views: 1033


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)